raloxifene hydrochloride has been researched along with Lung Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bardaweel, SK; Rahal, BA | 1 |
| Abd-Rabou, AA; Almutairi, FM; Mohamed, MS | 1 |
| Christopoulos, S; Rivera, JA; Small, D; Trifiro, M | 1 |
| Dosik, M; Kaufman, R | 1 |
| Benetti-Pinto, CL; De Angelo-Andrade, LA; Petta, CA; Soares, PM | 1 |
| Best, KL; Counts, DF; Goode, RL; Hoover, DM; Jones, CD; Merriman, RL; Neubauer, BL; Sarosdy, MF; Shaar, CJ; Tanzer, LR | 1 |
1 review(s) available for raloxifene hydrochloride and Lung Neoplasms
| Article | Year |
|---|---|
Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Brachial Plexus Neuropathies; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasms; Nitriles; Radiography, Thoracic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triazoles; Uterine Neoplasms | 2004 |
5 other study(ies) available for raloxifene hydrochloride and Lung Neoplasms
| Article | Year |
|---|---|
Implications and Efficacy of Aromatase Inhibitors in Combination and Monotherapy for the Treatment of Lung Cancer.
Topics: Agar; Annexins; Apoptosis; Aromatase; Aromatase Inhibitors; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cisplatin; Curcumin; Humans; Lung Neoplasms; Propidium; Raloxifene Hydrochloride | 2022 |
Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Humans; Hyaluronic Acid; Lung Neoplasms; Malondialdehyde; Nanoparticles; Nitric Oxide; Particle Size; Raloxifene Hydrochloride | 2019 |
Raloxifene rebound regression.
Topics: Antineoplastic Agents; Bone Diseases, Metabolic; Breast Neoplasms; Carcinoma, Ductal; Cyclophosphamide; Doxorubicin; Estrogen Antagonists; Female; Fluorouracil; Humans; Lung Neoplasms; Middle Aged; Raloxifene Hydrochloride; Remission Induction; Selective Estrogen Receptor Modulators; Tamoxifen | 2004 |
Pulmonary benign metastasizing leiomyoma: a report of 2 cases with different outcomes.
Topics: Adult; Estrogen Antagonists; Female; Humans; Leiomyomatosis; Lung; Lung Neoplasms; Middle Aged; Myometrium; Ovariectomy; Raloxifene Hydrochloride; Treatment Outcome; Uterine Neoplasms | 2006 |
Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model.
Topics: Adenocarcinoma; Adrenal Glands; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fluorouracil; Incidence; Lung Neoplasms; Lymphatic Metastasis; Male; Organ Size; Piperidines; Prostate; Prostatic Neoplasms; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Wistar; Survival Rate; Testis; Weight Gain | 1995 |